BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26373425)

  • 1. 1H, 15N and 13C backbone assignments of GDP-bound human H-Ras mutant G12V.
    Amin N; Chiarparin E; Coyle J; Nietlispach D; Williams G
    Biomol NMR Assign; 2016 Apr; 10(1):121-3. PubMed ID: 26373425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMR
    Sharma AK; Lee SJ; Rigby AC; Townson SA
    Biomol NMR Assign; 2018 Oct; 12(2):269-272. PubMed ID: 29721757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMR
    Yuan C; Hansen AL; Bruschweiler-Li L; Brüschweiler R
    Biomol NMR Assign; 2024 Jun; 18(1):7-13. PubMed ID: 37948018
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Pálfy G; Vida I; Perczel A
    Biomol NMR Assign; 2020 Apr; 14(1):1-7. PubMed ID: 31468366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMR
    Sharma AK; Lee SJ; Zhou M; Rigby AC; Townson SA
    Biomol NMR Assign; 2019 Apr; 13(1):227-231. PubMed ID: 30798456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence-specific 1H and 15N resonance assignments and secondary structure of GDP-bound human c-Ha-Ras protein in solution.
    Muto Y; Yamasaki K; Ito Y; Yajima S; Masaki H; Uozumi T; Wälchli M; Nishimura S; Miyazawa T; Yokoyama S
    J Biomol NMR; 1993 Mar; 3(2):165-84. PubMed ID: 8477185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solution structure and dynamics of ras p21.GDP determined by heteronuclear three- and four-dimensional NMR spectroscopy.
    Kraulis PJ; Domaille PJ; Campbell-Burk SL; Van Aken T; Laue ED
    Biochemistry; 1994 Mar; 33(12):3515-31. PubMed ID: 8142349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assignments of backbone ¹H, ¹³C and ¹⁵N resonances in H-Ras (1-166) complexed with GppNHp at physiological pH.
    O'Connor C; Kovrigin EL
    Biomol NMR Assign; 2012 Apr; 6(1):91-3. PubMed ID: 21814767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential assignment of the backbone nuclei (1H, 15N and 13C) of c-H-ras p21 (1-166).GDP using a novel 4D NMR strategy.
    Campbell-Burk SL; Domaille PJ; Starovasnik MA; Boucher W; Laue ED
    J Biomol NMR; 1992 Nov; 2(6):639-46. PubMed ID: 1337001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic mechanisms of mutation-dependent Harvey Ras activation and their relevance for the development of Costello syndrome.
    Wey M; Lee J; Jeong SS; Kim J; Heo J
    Biochemistry; 2013 Nov; 52(47):8465-79. PubMed ID: 24224811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional polysterism in the GTP-bound form of the human c-Ha-Ras protein.
    Ito Y; Yamasaki K; Iwahara J; Terada T; Kamiya A; Shirouzu M; Muto Y; Kawai G; Yokoyama S; Laue ED; Wälchli M; Shibata T; Nishimura S; Miyazawa T
    Biochemistry; 1997 Jul; 36(30):9109-19. PubMed ID: 9230043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GTP Binding and Oncogenic Mutations May Attenuate Hypervariable Region (HVR)-Catalytic Domain Interactions in Small GTPase K-Ras4B, Exposing the Effector Binding Site.
    Lu S; Banerjee A; Jang H; Zhang J; Gaponenko V; Nussinov R
    J Biol Chem; 2015 Nov; 290(48):28887-900. PubMed ID: 26453300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence-specific 1H, 13C, and 15N backbone assignment of the GTPase rRheb in its GDP-bound form.
    Berghaus C; Schwarten M; Heumann R; Stoll R
    Biomol NMR Assign; 2007 Jul; 1(1):45-7. PubMed ID: 19636822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ¹H, ¹³C and ¹⁵N resonance assignment for the human K-Ras at physiological pH.
    Vo U; Embrey KJ; Breeze AL; Golovanov AP
    Biomol NMR Assign; 2013 Oct; 7(2):215-9. PubMed ID: 22886485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-frequency 94 GHz ENDOR characterization of the metal binding site in wild-type Ras x GDP and its oncogenic mutant G12V in frozen solution.
    Bennati M; Hertel MM; Fritscher J; Prisner TF; Weiden N; Hofweber R; Spörner M; Horn G; Kalbitzer HR
    Biochemistry; 2006 Jan; 45(1):42-50. PubMed ID: 16388579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural differences between valine-12 and aspartate-12 Ras proteins may modify carcinoma aggression.
    Al-Mulla F; Milner-White EJ; Going JJ; Birnie GD
    J Pathol; 1999 Mar; 187(4):433-8. PubMed ID: 10398103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dynamics simulations of Gly-12-->Val mutant of p21(ras): dynamic inhibition mechanism.
    Futatsugi N; Tsuda M
    Biophys J; 2001 Dec; 81(6):3483-8. PubMed ID: 11721009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative MD simulations and advanced analytics based studies on wild-type and hot-spot mutant A59G HRas.
    Sharma N; Sonavane U; Joshi R
    PLoS One; 2020; 15(10):e0234836. PubMed ID: 33064725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct dynamics and interaction patterns in H- and K-Ras oncogenic P-loop mutants.
    Sayyed-Ahmad A; Prakash P; Gorfe AA
    Proteins; 2017 Sep; 85(9):1618-1632. PubMed ID: 28498561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMR
    Sharma AK; Dyba M; Tonelli M; Smith B; Gillette WK; Esposito D; Nissley DV; McCormick F; Maciag AE
    Biomol NMR Assign; 2022 Apr; 16(1):1-8. PubMed ID: 34686998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.